Shiga Toxin-Producing E. coli and Hemolytic Uremic Syndrome: A Study of the 2022 Outbreak in Turkey

09 December 2024 : Clinical Research

Oğuzhan Zengin

^{ABCDEFG 1*}, Burak Göre

^{ABCDEFG 1}, Oğuz Öztürk

^{ABCDEFG 2}, Muhammet Göv

^{ABCDEFG 1}, Enes Seyda Şahiner

^{ABCDEFG 1}, Osman İnan

^{ABCDEFG 1}, Emra Asfuroğlu Kalkan

^{ABCDEFG 1}, Şimal Kösal Cevher

^{ABCDEFG 3}, Ahmet Kürşad Güneş

^{ABCDEFG 4}, Gülsüm Özet

^{ABCDEFG 5}, İhsan Ateş

^{ABCDEFG 1}

DOI: 10.12659/MSM.946033

Med Sci Monit 2024; 30:e946033

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 7 Comparison of laboratory test results at the time of hospitalization, according to plasmapheresis treatment.

On admission	Plasmapheresis treatment		P
	No	Yes
	Mean±SD	Mean±SD
Hemoglobin (g/dL)	11.76±1.58	10.41±1.35	0.073
Platelet (10/L)	126.285±134.446	57.285±19.189	0.067
White blood count (10/L)	15.451±5.494	18.008±7.971	0.654
Hematocrit (%)	36.16±4.32	31.57±4.63	0.062
	1.84±1.17	3.35±1.56
Glomerular filtration rate (mL/min/1.73 m)	43.61±21.69	27.89±28.98	0.052
	796.57±444.51	1544.14±762.67
Total bilirubin (mg/dL)	1.52±1.03	1.64±1.11	0.765
Indirect bilirubin (mg/dL)	0.88±.58	1.14±.73	0.296
	40.79±12.34	106.43±83.65
Lipase (U/L)	35.67±11.92	54.3±41.26	0.970
Troponin-I (ng/L)	517.14±1890.67	111.98±120.33	0.062
NT-ProBNP (ng/L)	2444±2070.92	14735.43±14964.46	0.117
Analysis conducted with the Mann-Whitney U test. NT-proBNP – N-terminus pro-B-type natriuretic peptide.

Back to the Article